The four cough syrups are identified as Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup. The products are produced by an Indian company, Maiden Pharmaceuticals.
WHO says that the company issued the products into the market without proper authentication and warranty as required by the World Health Organization.
In an article published on its official website, the WHO states, "The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup. The stated manufacturer of these products is Maiden Pharmaceuticals Limited (Haryana, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products".
"Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants. To date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions," the WHO added.
The WHO also announced that Diethylene glycol and ethylene glycol are toxic to humans when consumed and can prove fatal.
In an article published on its official website, the WHO states, "The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup. The stated manufacturer of these products is Maiden Pharmaceuticals Limited (Haryana, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products".
"Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants. To date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions," the WHO added.
The WHO also announced that Diethylene glycol and ethylene glycol are toxic to humans when consumed and can prove fatal.
The listed toxic effects of the drug include abdominal pain, vomiting, diarrhea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.
The organization ordered that all batches of the products should be considered unsafe until they can be analyzed by the relevant National Regulatory Authorities.
The Indian authority, however, had refuted the WHO claim and requested the organization to provide laboratory evidence that the medicine was the cause of the 66 children deaths in The Gambia as reported.
Posts
